{"id":48654,"date":"2022-09-21T16:01:38","date_gmt":"2022-09-21T14:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/"},"modified":"2022-09-21T16:01:38","modified_gmt":"2022-09-21T14:01:38","slug":"wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/","title":{"rendered":"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness"},"content":{"rendered":"
\n

WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health<\/a> today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness.\n<\/p>\n

<\/a><\/p>\n

\nIn his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice President and General Manager of the Transactional & Retirement Portfolio in Wolters Kluwer\u2019s Legal & Regulatory division, where he oversaw a portfolio of SaaS solutions and expert content serving legal and compliance professionals.\n<\/p>\n

\nIn his new role, Sullivan will lead the Commercial Segment with responsibility for setting strategy and driving growth of its clinical decision support (CDS) solutions including Medi-Span\u00ae<\/sup>, Lexicomp\u00ae<\/sup>, UpToDate\u00ae<\/sup> and Emmi\u00ae<\/sup>. The segment provides expert content and workflow tools to professionals in the pharmacy, digital health technology, and commercial payer markets. Sullivan reports to Greg Samios, President and CEO of Clinical Effectiveness, Wolters Kluwer, Health.\n<\/p>\n

\n\u201cExpanding our footprint in the commercial market is a critical part of our overall strategy,\u201d said Samios. \u201cWith his strong background and proven results at Wolters Kluwer, I am confident that Chris will scale our commercial footprint as we accelerate development of impactful solutions for our customers.\u201d\n<\/p>\n

\n\u201cI\u2019m honored to lead the Commercial Segment as we ramp up investment in the business,\u201d said Sullivan. \u201cThese are pivotal times in healthcare\u2014our portfolio is the lifeblood of clinicians worldwide, and we are committed to helping our clients achieve better outcomes at greater speed.\u201d\n<\/p>\n

\nPrior to joining Wolters Kluwer, Sullivan held a variety of operations management roles at DHL. He earned an MBA from Fordham University and a BS from the United States Military Academy at West Point.\n<\/p>\n

\nAbout Wolters Kluwer
\n
<\/b>Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.\n<\/p>\n

\nWolters Kluwer reported 2020 annual revenues of \u20ac4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.\n<\/p>\n

\nWolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https:\/\/www.wolterskluwer.com\/en\/health<\/a> and follow us on LinkedIn<\/a> and Twitter @WKHealth<\/a>.\n<\/p>\n

\nFor more information, visit www.wolterskluwer.com<\/a>, follow us on Twitter<\/a>, Facebook<\/a>, LinkedIn<\/a>, and YouTube<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Andr\u00e9 Rebelo
\n
Sr. Global Public Relations Manager
\n
Wolters Kluwer Health
\n
+1 (781) 392-2411
\n
andre.rebelo@wolterskluwer.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness. In his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48654","6":"format-standard","7":"category-industry"},"yoast_head":"\nWolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness. In his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-21T14:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220921005261\/en\/839232\/21\/Wolters-Kluwer-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness\",\"datePublished\":\"2022-09-21T14:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/\"},\"wordCount\":477,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005261\\\/en\\\/839232\\\/21\\\/Wolters-Kluwer-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/\",\"name\":\"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005261\\\/en\\\/839232\\\/21\\\/Wolters-Kluwer-logo.jpg\",\"datePublished\":\"2022-09-21T14:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005261\\\/en\\\/839232\\\/21\\\/Wolters-Kluwer-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005261\\\/en\\\/839232\\\/21\\\/Wolters-Kluwer-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/","og_locale":"en_US","og_type":"article","og_title":"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness - Pharma Trend","og_description":"WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness. In his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-21T14:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220921005261\/en\/839232\/21\/Wolters-Kluwer-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness","datePublished":"2022-09-21T14:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/"},"wordCount":477,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220921005261\/en\/839232\/21\/Wolters-Kluwer-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/","url":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/","name":"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220921005261\/en\/839232\/21\/Wolters-Kluwer-logo.jpg","datePublished":"2022-09-21T14:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220921005261\/en\/839232\/21\/Wolters-Kluwer-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220921005261\/en\/839232\/21\/Wolters-Kluwer-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/wolters-kluwer-names-chris-sullivan-vice-president-commercial-segment-for-clinical-effectiveness\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48654"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48654\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}